14.95% 0.3901

Oncology Institute Inc (TOI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Oncology Institute Inc-Aktie (TOI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	136.56	-	104.41	100.27	99.90
Operating Expenses	144.62	-	114.32	112.20	113.75
Benefits Costs and Expenses	153.07	-	123.99	113.45	116.01
Costs And Expenses	153.07	-	123.99	113.45	116.01
Depreciation and Amortization	1.723	-	1.784	1.707	1.573
Operating Income/Loss	-8.054	-	-9.911	-11.93	-13.85
Nonoperating Income/Loss	-8.45	-	-9.674	-1.253	-2.26
Income/Loss From Continuing Operations Before Tax	2.97% -16.50	-17.01	-19.59	-13.18	-16.11
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.97% -16.50	-17.01	-19.59	-13.18	-16.11
Net Income/Loss	2.97% -16.50	-17.01	-19.59	-13.18	-16.11
Preferred Stock Dividends And Other Adjustments	-2.734	-	-	-2.356	-2.89
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.47	-	77.10	0.2053	75.52
Diluted Average Shares	97.47	-	77.10	0.2053	75.52
Basic Earnings Per Share	-0.14	-	-0.21	-0.15	-0.18
Diluted Earnings Per Share	-0.14	-	-0.21	-0.15	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-2.734	-	-3.51	-2.356	-2.89

OPCH

$29.85

1.05%

PACS

$34.34

1.90%

CHE

$403.43

0.80%

EHC

$100.14

0.17%

DVA

$149.65

2.24%

UHS

$193.34

1.59%